You searched for "implant"
Insights in resistant diabetic macular oedema
5 August 2022
| Sofia Rokerya
|
EYE - Vitreo-Retinal
This article gives a bird’s eye review of the different modalities for the treatment of diabetic macular oedema (DME). The debut of anti-VEGFs has brought a paradigm shift in DME management. This treatment has now become a major breakthrough in...
Sight Sciences OMNI® Masterclass, Colchester
23 January 2023
|
Awards, Conferences & Anniversaries
Saturday 14th January saw Sight Sciences hold their third UK Masterclass for the OMNI Surgical System.
What's trending Apr/May 2022
5 April 2022
| Stephanie Chiu
|
EYE - General
A round-up of the eye-related hot topics that have been trending over the last few weeks. #ArgusI #ArgusII #bioniceye #retinitispigmentosa #SecondSight Remember Argus I & Argus II? Its star burned bright, touted as the future of treatment for retinitis pigmentosa....
Sharing best practice and landmark evidence in glaucoma care
Evolving technology, best practice and landmark evidence in glaucoma care were reviewed by an international expert faculty in session presentations and debates during the 11th Moorfields International Glaucoma Symposium 2019. The authors were meeting chairs and provide an overview of...ESASO Course Series (Volume 3): Cataract
This book is designed as a course manual for cataract and refractive surgery. It starts off by discussing both the fluidics and dynamics of phacoemulsification, touching techniques and management of difficult scenarios. The ins and outs of conventional, accommodative, toric...Preview: UKISCRS 48th Annual Congress 2024
22 November 2024
|
conference, meetings, events, UKISCRS, cataract, refraction, United Kingdom, Ireland, Eire, society, London, David Lockington, Paul Ursell, YOP, UKISOP, Rebecca Turner
One of the biggest UKISCRS events is upon us, and we’ll all by making our way down there in the next several weeks or so. Not only is it the 75th anniversary of the IOL, but it is also the...
Methotrexate and mycophenolate mofetil for non-infectious uveitis
1 February 2015
| Brian Ang
|
EYE - Vitreo-Retinal
This is the first reported randomised clinical trial comparing methotrexate versus mycophenolate mofetil (MMF) for the treatment of non-infectious intermediate uveitis, posterior uveitis or panuveitis. To be eligible for recruitment, patients had to be on ≥15mg oral prednisone and demonstrated...